496 related articles for article (PubMed ID: 29295665)
21. Prolonged non-invasive ventilation in extremely low birth weight preterm infants is associated with bronchopulmonary dysplasia.
Chabra S; Strandjord T; Peeples E
J Neonatal Perinatal Med; 2019; 12(3):249-253. PubMed ID: 30932902
[TBL] [Abstract][Full Text] [Related]
22. Neonatal outcome of small for gestational age preterm infants.
Nobile S; Marchionni P; Carnielli VP
Eur J Pediatr; 2017 Aug; 176(8):1083-1088. PubMed ID: 28660312
[TBL] [Abstract][Full Text] [Related]
23. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.
Rigo V; Lefebvre C; Broux I
Eur J Pediatr; 2016 Dec; 175(12):1933-1942. PubMed ID: 27678511
[TBL] [Abstract][Full Text] [Related]
24. Fraction of Inspired Oxygen as a Predictor of CPAP Failure in Preterm Infants with Respiratory Distress Syndrome: A Prospective Multicenter Study.
Gulczyńska E; Szczapa T; Hożejowski R; Borszewska-Kornacka MK; Rutkowska M
Neonatology; 2019; 116(2):171-178. PubMed ID: 31112987
[TBL] [Abstract][Full Text] [Related]
25. Increased ADMA levels are associated with poor pulmonary outcome in preterm neonates.
Kavurt S; Demirel N; Bas AY; Ulubas Isık D; Ozcan B; Aydemir O
J Matern Fetal Neonatal Med; 2017 Apr; 30(7):864-869. PubMed ID: 27268203
[TBL] [Abstract][Full Text] [Related]
26. Occurrence, predictive factors and associated morbidity of bronchopulmonary dysplasia in a preterm birth cohort.
Hakulinen A; Heinonen K; Jokela V; Kiekara O
J Perinat Med; 1988; 16(5-6):437-46. PubMed ID: 3241290
[TBL] [Abstract][Full Text] [Related]
27. Compared to CPAP extubation to non-invasive ventilation is associated with higher risk of bronchopulmonary dysplasia in extremely low birth weight infants.
Abu-Shaweesh JM; Khasawneh W; Tang AS; Worley S; Saker F
J Neonatal Perinatal Med; 2020; 13(2):183-188. PubMed ID: 31658069
[TBL] [Abstract][Full Text] [Related]
28. Changes in the patterns of respiratory support and incidence of bronchopulmonary dysplasia; a single center experience.
Algarni SS; Ali K; Alsaif S; Aljuaid N; Alzahrani R; Albassam M; Alanazi R; Alqueflie D; Almutairi M; Alfrijan H; Alanazi A; Ghazwani A; Alshareedah S; Alotaibi TF; Alqahtani MM; Aljohani H; Ismaeil TT; Alwadeai KS; Siraj RA; Alsaif A; Asiri S; Halabi S; Alanazi AMM
BMC Pediatr; 2023 Jul; 23(1):357. PubMed ID: 37442954
[TBL] [Abstract][Full Text] [Related]
29. Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial.
Oncel MY; Arayici S; Uras N; Alyamac-Dizdar E; Sari FN; Karahan S; Canpolat FE; Oguz SS; Dilmen U
Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F323-8. PubMed ID: 26553376
[TBL] [Abstract][Full Text] [Related]
30. [Risk factors for moderate/severe bronchopulmonary dysplasia in preterm infants with a gestational age of <32 weeks: a multicenter retrospective analysis].
Jiangsu Province Neonatal Perinatal Cooperation Network
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1104-1110. PubMed ID: 36305110
[TBL] [Abstract][Full Text] [Related]
31. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive Support: Does It Really Decrease Bronchopulmonary Dysplasia?
Wright CJ; Polin RA
Clin Perinatol; 2016 Dec; 43(4):783-798. PubMed ID: 27837759
[TBL] [Abstract][Full Text] [Related]
33. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
[TBL] [Abstract][Full Text] [Related]
34. Chorioamnionitis alters the response to surfactant in preterm infants.
Been JV; Rours IG; Kornelisse RF; Jonkers F; de Krijger RR; Zimmermann LJ
J Pediatr; 2010 Jan; 156(1):10-15.e1. PubMed ID: 19833352
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the effects of invasive mechanic ventilation/surfactant therapy and non-invasive nasal-continuous positive airway pressure in preterm newborns.
Celik M; Bulbul A; Uslu S; Dursun M; Guran O; Kıray Bas E; Arslan S; Zubarioglu U
J Matern Fetal Neonatal Med; 2018 Dec; 31(24):3225-3231. PubMed ID: 28856971
[TBL] [Abstract][Full Text] [Related]
36. Incidence and prediction of bronchopulmonary dysplasia in a cohort of premature infants.
Farstad T; Bratlid D
Acta Paediatr; 1994 Jan; 83(1):19-24. PubMed ID: 8193467
[TBL] [Abstract][Full Text] [Related]
37. [Establishment and efficiency test of a clinical prediction model of bronchopulmonary dysplasia associated pulmonary hypertension in very premature infants].
Cao JK; Fan HQ; Xiao YB; Wang D; Liu CG; Peng XM; Gao XR; Tang SH; Han T; Mei YB; Liang HY; Wang SM; Wang F; Li QP
Zhonghua Er Ke Za Zhi; 2024 Feb; 62(2):129-137. PubMed ID: 38264812
[No Abstract] [Full Text] [Related]
38. Bronchopulmonary dysplasia in infants with respiratory distress syndrome in a developing country: a prospective single centre-based study.
Smith J; Kling S; Gie RP; van Zyl J; Kirsten GF; Nel ED; Schneider JW
Eur J Pediatr; 1996 Aug; 155(8):672-7. PubMed ID: 8839723
[TBL] [Abstract][Full Text] [Related]
39. Early neonatal outcomes of volume guaranteed ventilation in preterm infants with respiratory distress syndrome.
Guven S; Bozdag S; Saner H; Cetinkaya M; Yazar AS; Erguven M
J Matern Fetal Neonatal Med; 2013 Mar; 26(4):396-401. PubMed ID: 23039373
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants.
Weber B; Borkhardt A; Stoll-Becker S; Reiss I; Gortner L
Turk J Pediatr; 2000; 42(3):181-5. PubMed ID: 11105614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
